Hearing Loss Trial, Recruiting (NCT07211711)

Hearing Loss Trial, Recruiting NCT07211711 Sponsor: University of Sao Paulo General Hospital Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT07211711 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have been experiencing both tinnitus (ringing in the ears related to touch or movement) and jaw joint problems (TMD) for more than 6 months
Your teeth are in good health, with enough teeth on both sides of your mouth at least up to the second-to-last small back teeth
You are able to attend follow-up appointments for at least 4 months
You are able to speak and read Portuguese

Who may not be able to join:

You are currently pregnant
You have received treatment for jaw joint problems (TMD) in the last 3 months
You have received treatment for tinnitus (ringing in the ears) in the last 3 months
You wear full or partial removable dentures
You have facial or mouth pain that is not related to jaw joint problems (TMD)
You have a medical reason that prevents you from receiving the treatment used in this trial (confirm with trial site)
You are not willing to accept whichever treatment is assigned to you in the trial
You are unable or unwilling to sign a consent form agreeing to take part
You have a language barrier or a condition affecting communication or development (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07211711

Sponsor: University of Sao Paulo General Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

More information: https://clinicaltrials.gov/study/NCT07211711

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have been experiencing both tinnitus (ringing in the ears related to touch or movement) and jaw joint problems (TMD) for more than 6 months
Your teeth are in good health, with enough teeth on both sides of your mouth at least up to the second-to-last small back teeth
You are able to attend follow-up appointments for at least 4 months
You are able to speak and read Portuguese

Who may not be able to join:

You are currently pregnant
You have received treatment for jaw joint problems (TMD) in the last 3 months
You have received treatment for tinnitus (ringing in the ears) in the last 3 months
You wear full or partial removable dentures
You have facial or mouth pain that is not related to jaw joint problems (TMD)
You have a medical reason that prevents you from receiving the treatment used in this trial (confirm with trial site)
You are not willing to accept whichever treatment is assigned to you in the trial
You are unable or unwilling to sign a consent form agreeing to take part
You have a language barrier or a condition affecting communication or development (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Sao Paulo General Hospital

Registry

ClinicalTrials.gov

Start date

10 August 2023

Est. completion

31 December 2025

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Changes in somatosensory tinnitus after treatment of temporomandibular joint disorder with a stabilizing occlusal splint.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov